These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 24954346)

  • 21. Exploring botulinum toxin's impact on masseter hypertrophy: a randomized, triple-blinded clinical trial.
    de Souza Nobre BB; Rezende L; Barbosa Câmara-Souza M; Sanchez-Ayala A; Blass R; Carbone AC; Manso AC; Ernberg M; Christidis N; De la Torre Canales G
    Sci Rep; 2024 Jun; 14(1):14522. PubMed ID: 38914688
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Three-dimensional CT might be a potential evaluation modality in correction of asymmetrical masseter muscle hypertrophy by botulinum toxin injection.
    No YA; Ahn BH; Kim BJ; Kim MN; Hong CK
    J Cosmet Laser Ther; 2016; 18(2):113-5. PubMed ID: 26073120
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The use of botulinum toxin type A in masseter muscle hypertrophy: long-term effects and lasting improvement].
    Aydil B; Başaran B; Unsaler S; Süoğlu Y
    Kulak Burun Bogaz Ihtis Derg; 2012; 22(5):249-53. PubMed ID: 22991984
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Botulinum toxin a for lower facial contouring: a prospective study.
    Yu CC; Chen PK; Chen YR
    Aesthetic Plast Surg; 2007; 31(5):445-51; discussion 452-3. PubMed ID: 17674088
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of botulinum toxin type A injection into human masseter muscle on stimulated parotid saliva flow rate.
    Kwon JS; Kim ST; Jeon YM; Choi JH
    Int J Oral Maxillofac Surg; 2009 Apr; 38(4):316-20. PubMed ID: 19231136
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The topographic anatomy of the masseteric nerve: A cadaveric study with an emphasis on the effective zone of botulinum toxin A injections in masseter.
    Kaya B; Apaydin N; Loukas M; Tubbs RS
    J Plast Reconstr Aesthet Surg; 2014 Dec; 67(12):1663-8. PubMed ID: 25175271
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Electrophysiologic change and facial contour following botulinum toxin A injection in square faces.
    Lee CJ; Kim SG; Kim YJ; Han JY; Choi SH; Lee SI
    Plast Reconstr Surg; 2007 Sep; 120(3):769-778. PubMed ID: 17700130
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Classification of masseter hypertrophy for tailored botulinum toxin type A treatment.
    Xie Y; Zhou J; Li H; Cheng C; Herrler T; Li Q
    Plast Reconstr Surg; 2014 Aug; 134(2):209e-218e. PubMed ID: 25068343
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of botulinum toxin injection on length and force of the rectus femoris and triceps surae muscles during locomotion in patients with chronic hemiparesis (FOLOTOX).
    Supiot A; Geiger M; Bensmail D; Aegerter P; Pradon D; Roche N
    BMC Neurol; 2018 Aug; 18(1):104. PubMed ID: 30068305
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effectiveness of botulinum toxin type A for the treatment of chronic masticatory myofascial pain: A case series.
    Baker JS; Nolan PJ
    J Am Dent Assoc; 2017 Jan; 148(1):33-39. PubMed ID: 28314397
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of Botulinum Toxin in Treating Asian Indian Patients with Masseter Hypertrophy: A 4-Year Follow-Up Study.
    Shome D; Khare S; Kapoor R
    Plast Reconstr Surg; 2019 Sep; 144(3):390e-396e. PubMed ID: 31461011
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Botulinum Toxin Injections for Masseter Reduction in East Asians.
    Cheng J; Hsu SH; McGee JS
    Dermatol Surg; 2019 Apr; 45(4):566-572. PubMed ID: 30883483
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lower facial remodeling with botulinum toxin type A for the treatment of masseter hypertrophy.
    Klein FH; Brenner FM; Sato MS; Robert FM; Helmer KA
    An Bras Dermatol; 2014; 89(6):878-84. PubMed ID: 25387491
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Management of unilateral idiopathic masseter muscle hypertrophy with botulinum toxin type A.
    Nilesh K; Dharamsi R; Patil P; Mate P
    BMJ Case Rep; 2021 Jan; 14(1):. PubMed ID: 33462041
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Botulinum toxin type A in the management of masseter muscle hypertrophy.
    Castro WH; Gomez RS; Da Silva Oliveira J; Moura MD; Gomez RS
    J Oral Maxillofac Surg; 2005 Jan; 63(1):20-4. PubMed ID: 15635552
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Commentary.
    De Almeida AR
    Dermatol Surg; 2009 Dec; 35(12):1907. PubMed ID: 20050146
    [No Abstract]   [Full Text] [Related]  

  • 37. [Quantitative analysis based on three-dimensional stereophotogrammetry in the observation of curative effect of botulinum toxin A on masseter hypertrophy].
    Xue Z; Zeng W; Chen Z; Han Y
    Zhonghua Zheng Xing Wai Ke Za Zhi; 2016 Jul; 32(4):272-5. PubMed ID: 30044570
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Botulinum Toxin-Induced Parotitis: A Postoperative Complication Following Masseter Muscle Injection.
    Grinberg N; Whitefield S; Kleinman S; Frenkel G; Peleg O
    J Oral Maxillofac Surg; 2024 May; 82(5):525-530. PubMed ID: 38438110
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bone and cartilage changes in rabbit mandibular condyles after 1 injection of botulinum toxin.
    Matthys T; Ho Dang HA; Rafferty KL; Herring SW
    Am J Orthod Dentofacial Orthop; 2015 Dec; 148(6):999-1009. PubMed ID: 26672706
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy and Safety of a Novel Botulinum Toxin A for Masseter Reduction: A Randomized, Double-Blind, Placebo-Controlled, Optimal Dose-Finding Study.
    Hong JY; Jeong GJ; Kwon TR; Kim JH; Li K; Kim BJ
    Dermatol Surg; 2021 Jan; 47(1):e5-e9. PubMed ID: 33347002
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.